CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.2.1. List of key players profiled in the report
1.3. Research methodology
1.3.1. Primary research
1.3.2. Secondary research
1.3.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. Key findings
2.2.1. Top impacting factors
2.2.2. Top investment pockets
2.3. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key Forces Shaping Biomarker technologies Industry/Market
3.2.1. Moderate bargaining power of supplier
3.2.2. Low bargaining power of buyers
3.2.3. Low threat of substitutes
3.2.4. High intensity of rivalry
3.2.5. Low threat of new entrant
3.3. Pricing Analysis
3.3.1. Pricing Analysis of Biomarker technologies, By Region, 2018 & 2025
3.4. Market evolution/Industry roadmap
3.5. Value Chain Analysis
3.6. Impact of government regulations on global biomarker technologies market
3.7. Industry Pain point analysis
3.8. Market dynamics
3.8.1. Drivers
3.8.1.1. Rise in prevalence of various diseases
3.8.1.2. Surge in R&D activities in healthcare coupled with rise in adoption of early toxicity testing
3.8.1.3. Advantages offered by biomarker in drug development
3.8.1.4. Increase in genome mapping programs
3.8.2. Restraints
3.8.2.1. High initial capital investments required for biomarker discovery
3.8.2.2. Lack of awareness regarding the use of biomarker technologies
3.8.3. Opportunity
3.8.3.1. High potential of the emerging economies
3.8.4. Impact Analyses
CHAPTER 4: BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT AND SERVICES
4.1. Overview
4.2. Consumables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Reagents
4.2.2.1.1. Market size and forecast
4.2.2.2. Assays
4.2.2.2.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis by country
CHAPTER 5: BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY
5.1. Overview
5.2. Polymerase Chain Reaction (PCR)
5.2.1. Market size and forecast, by region
5.2.2. Market analysis by country
5.3. Next Generation Sequencing (NGS)
5.3.1. Market size and forecast, by region
5.3.2. Market analysis by country
5.4. Immunoassay
5.4.1. Market size and forecast, by region
5.4.2. Market analysis by country
5.5. Others
5.5.1. Market size and forecast, by region
5.5.2. Market analysis by country
CHAPTER 6: BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION
6.1. Overview
6.2. Drug Discovery
6.2.1. Market size and forecast, by region
6.2.2. Market analysis by country
6.3. Diagnostics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis by country
6.4. Personalized Medicine
6.4.1. Market size and forecast, by region
6.4.2. Market analysis by country
CHAPTER 7: BIOMARKER TECHNOLOGIES MARKET, BY INDICATION
7.1. Overview
7.2. Cancer
7.2.1. Market size and forecast, by region
7.2.2. Market analysis by country
7.3. Infectious Diseases
7.3.1. Market size and forecast, by region
7.3.2. Market analysis by country
7.4. Autoimmune Disorders
7.4.1. Market size and forecast, by region
7.4.2. Market analysis by country
7.5. Cardiovascular Disorders
7.5.1. Market size and forecast, by region
7.5.2. Market analysis by country
7.6. Others
7.6.1. Market size and forecast, by region
7.6.2. Market analysis by country
CHAPTER 8: BIOMARKER TECHNOLOGIES MARKET, BY REGION
8.1. Overview
8.2. North America
8.2.1. Key market trends and opportunities
8.2.2. Market analysis by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. market size and forecast, by product and services
8.2.2.1.2. U.S. market size and forecast, by technology
8.2.2.1.3. U.S. market size and forecast, by application
8.2.2.1.4. U.S. market size and forecast, by indication
8.2.2.2. Canada
8.2.2.2.1. Canada market size and forecast, by product and services
8.2.2.2.2. Canada market size and forecast, by technology
8.2.2.2.3. Canada market size and forecast, by application
8.2.2.2.4. Canada market size and forecast, by indication
8.2.2.3. Mexico
8.2.2.3.1. Mexico market size and forecast, by product and services
8.2.2.3.2. Mexico market size and forecast, by technology
8.2.2.3.3. Mexico market size and forecast, by application
8.2.2.3.4. Mexico market size and forecast, by indication
8.2.3. North America market size and forecast, by product and services
8.2.4. North America market size and forecast, by technology
8.2.5. North America market size and forecast, by application
8.2.6. North America market size and forecast, by indication
8.3. Europe
8.3.1. Key market trends and opportunities
8.3.2. Market analysis by country
8.3.2.1. Germany
8.3.2.1.1. Germany market size and forecast, by product and services
8.3.2.1.2. Germany market size and forecast, by technology
8.3.2.1.3. Germany market size and forecast, by application
8.3.2.1.4. Germany market size and forecast, by indication
8.3.2.2. France
8.3.2.2.1. France market size and forecast, by product and services
8.3.2.2.2. France market size and forecast, by technology
8.3.2.2.3. France market size and forecast, by application
8.3.2.2.4. France market size and forecast, by indication
8.3.2.3. UK
8.3.2.3.1. UK market size and forecast, by product and services
8.3.2.3.2. UK market size and forecast, by technology
8.3.2.3.3. UK market size and forecast, by application
8.3.2.3.4. UK market size and forecast, by indication
8.3.2.4. Italy
8.3.2.4.1. Italy market size and forecast, by product and services
8.3.2.4.2. Italy market size and forecast, by technology
8.3.2.4.3. Italy market size and forecast, by application
8.3.2.4.4. Italy market size and forecast, by indication
8.3.2.5. Spain
8.3.2.5.1. Spain market size and forecast, by product and services
8.3.2.5.2. Spain market size and forecast, by technology
8.3.2.5.3. Spain market size and forecast, by application
8.3.2.5.4. Spain market size and forecast, by indication
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe market size and forecast, by product and services
8.3.2.6.2. Rest of Europe market size and forecast, by technology
8.3.2.6.3. Rest of Europe market size and forecast, by application
8.3.2.6.4. Rest of Europe market size and forecast, by indication
8.3.3. Europe market size and forecast, by product and services
8.3.4. Europe market size and forecast, by technology
8.3.5. Europe market size and forecast, by application
8.3.6. Europe market size and forecast, by indication
8.4. Asia-Pacific
8.4.1. Key market trends and opportunities
8.4.2. Market analysis by country
8.4.2.1. Japan
8.4.2.1.1. Japan market size and forecast, by product and services
8.4.2.1.2. Japan market size and forecast, by technology
8.4.2.1.3. Japan market size and forecast, by application
8.4.2.1.4. Japan market size and forecast, by indication
8.4.2.2. China
8.4.2.2.1. China market size and forecast, by product and services
8.4.2.2.2. China market size and forecast, by technology
8.4.2.2.3. China market size and forecast, by application
8.4.2.2.4. China market size and forecast, by indication
8.4.2.3. Australia
8.4.2.3.1. Australia market size and forecast, by product and services
8.4.2.3.2. Australia market size and forecast, by technology
8.4.2.3.3. Australia market size and forecast, by application
8.4.2.3.4. Australia market size and forecast, by indication
8.4.2.4. India
8.4.2.4.1. India market size and forecast, by product and services
8.4.2.4.2. India market size and forecast, by technology
8.4.2.4.3. India market size and forecast, by application
8.4.2.4.4. India market size and forecast, by indication
8.4.2.5. South Korea
8.4.2.5.1. South Korea market size and forecast, by product and services
8.4.2.5.2. South Korea market size and forecast, by technology
8.4.2.5.3. South Korea market size and forecast, by application
8.4.2.5.4. South Korea market size and forecast, by indication
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product and services
8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technology
8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application
8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by indication
8.4.3. Asia-Pacific market size and forecast, by product and services
8.4.4. Asia-Pacific market size and forecast, by technology
8.4.5. Asia-Pacific market size and forecast, by application
8.4.6. Asia-Pacific market size and forecast, by indication
8.5. LAMEA
8.5.1. Key market trends and opportunities
8.5.2. Market analysis by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil market size and forecast, by product and services
8.5.2.1.2. Brazil market size and forecast, by technology
8.5.2.1.3. Brazil market size and forecast, by application
8.5.2.1.4. Brazil market size and forecast, by indication
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia market size and forecast, by product and services
8.5.2.2.2. Saudi Arabia market size and forecast, by technology
8.5.2.2.3. Saudi Arabia market size and forecast, by application
8.5.2.2.4. Saudi Arabia market size and forecast, by indication
8.5.2.3. South Africa
8.5.2.3.1. South Africa market size and forecast, by product and services
8.5.2.3.2. South Africa market size and forecast, by technology
8.5.2.3.3. South Africa market size and forecast, by application
8.5.2.3.4. South Africa market size and forecast, by indication
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA market size and forecast, by product and services
8.5.2.4.2. Rest of LAMEA market size and forecast, by technology
8.5.2.4.3. Rest of LAMEA market size and forecast, by application
8.5.2.4.4. Rest of LAMEA market size and forecast, by indication
8.5.3. LAMEA market size and forecast, by product and services
8.5.4. LAMEA market size and forecast, by technology
8.5.5. LAMEA market size and forecast, by application
8.5.6. LAMEA market size and forecast, by indication
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. INTRODUCTION
9.1.1. MARKET PLAYER POSITIONING, 2018
9.2. MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018 (%)
9.3. TOP WINNING STRATEGIES
9.4. COMPETITIVE DASHBOARD
9.5. COMPETITIVE HEATMAP
CHAPTER 10: COMPANY PROFILES: BIOMARKER TECHNOLOGIES MARKET
10.1. AGILENT TECHNOLOGIES, INC.
10.1.1. Company overview
10.1.2. Company snapshot
10.1.3. Operating business segments
10.1.4. Product type Portfolio
10.1.5. Business performance
10.2. BIO-RAD LABORATORIES, INC.
10.2.1. Company overview
10.2.2. Company snapshot
10.2.3. Operating business segments
10.2.4. Product type Portfolio
10.2.5. Business performance
10.2.6. Key strategic moves and developments
10.3. F. HOFFMANN-LA ROCHE LTD.
10.3.1. Company overview
10.3.2. Company snapshot
10.3.3. Operating business segments
10.3.4. Product portfolio
10.3.5. Business performance
10.3.6. Key strategic moves and developments
10.4. Illumina, Inc.
10.4.1. Company overview
10.4.2. Company snapshot
10.4.3. Operating business segments
10.4.4. Product Portfolio
10.4.5. Business performance
10.5. LI-COR, Inc.
10.5.1. Company overview
10.5.2. Company snapshot
10.5.3. Operating business segments
10.5.4. Product portfolio
10.6. Merck KGAA
10.6.1. Company overview
10.6.2. Company snapshot
10.6.3. Operating business segments
10.6.4. Product portfolio
10.6.5. Business performance
10.6.6. Key strategic moves and developments
10.7. PERKINELMER INC.
10.7.1. Company overview
10.7.2. Company snapshot
10.7.3. Operating business segments
10.7.4. Product Portfolio
10.7.5. Business performance
10.8. QIAGEN N.V.
10.8.1. Company overview
10.8.2. Company snapshot
10.8.3. Product type portfolio
10.8.4. Business performance
10.9. Shimadzu Corporation
10.9.1. Company overview
10.9.2. Company snapshot
10.9.3. Operating business segments
10.9.4. Product portfolio
10.9.5. Business performance
10.11. Thermo Fisher Scientific, Inc.
10.11.1. Company overview
10.11.2. Company snapshot
10.11.3. Operating business segments
10.11.4. Product Portfolio
10.11.5. Business performance
10.12. Other Key Player Profile
10.12.1. Key player snapshot